Feds publish long-COVID disability coverage guidelines … Genesis’ targeted COVID-19 vaccine efforts increased uptake among Black, Hispanic employees … Israel may recommend Pfizer’s COVID-19 booster...
CMS to weigh national Medicare coverage for Aduhelm, other Alzheimer’s drugs
By
Alicia Lasek
Jul 14, 2021
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
Panel on non-invasive ventilation seeks to simplify ‘maze’ of regulation for device coverage
By
Alicia Lasek
Aug 20, 2021
Recommendations aimed at expediting CMS coverage determinations for non-invasive ventilation devices could help ensure that LTCF residents and others get quick access to lifesaving treatments.
Determining medically necessary Medicare coverage
By
Colleen Toebe
Dec 05, 2014
Accurate and thorough nursing documentation is the crucial factor in determining medical necessity. As nursing leaders in long-term care, we are obligated to ensure that Medicare documentation standards...
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.